Latest headcount
10,600
YoY change
+6.2%
Headcount CAGR
+14.1%
Revenue / employee
$486K
Employee count history for ResMed
| Fiscal year | Employees |
|---|---|
| 1996 | 229 |
| 1997 | 270 |
| 1998 | 373 |
| 1999 | 477 |
| 2000 | 605 |
| 2001 | 953 |
| 2002 | 1,250 |
| 2003 | 1,464 |
| 2004 | 1,520 |
| 2005 | 1,927 |
| 2006 | 2,500 |
| 2007 | 2,700 |
| 2008 | 2,700 |
| 2009 | 2,900 |
| 2010 | 3,200 |
| 2011 | 3,450 |
| 2012 | 3,700 |
| 2013 | 3,900 |
| 2014 | 4,100 |
| 2015 | 4,340 |
| 2016 | 5,250 |
| 2017 | 6,080 |
| 2018 | 5,940 |
| 2019 | 7,240 |
| 2020 | 7,770 |
| 2021 | 7,970 |
| 2022 | 8,160 |
| 2023 | 10,140 |
| 2024 | 9,980 |
| 2025 | 10,600 |
Revenue per employee for ResMed
Annual revenue divided by reported headcount, normalized to US dollars.
| Fiscal year | Revenue per employee (USD) |
|---|---|
| 1996 | $151K |
| 1997 | $182K |
| 1998 | $178K |
| 1999 | $186K |
| 2000 | $191K |
| 2001 | $163K |
| 2002 | $163K |
| 2003 | $187K |
| 2004 | $223K |
| 2005 | $221K |
| 2006 | $243K |
| 2007 | $265K |
| 2008 | $309K |
| 2009 | $317K |
| 2010 | $341K |
| 2011 | $360K |
| 2012 | $370K |
| 2013 | $388K |
| 2014 | $379K |
| 2015 | $387K |
| 2016 | $350K |
| 2017 | $340K |
| 2018 | $394K |
| 2019 | $360K |
| 2020 | $381K |
| 2021 | $401K |
| 2022 | $438K |
| 2023 | $416K |
| 2024 | $469K |
| 2025 | $486K |
Earnings per employee for ResMed
Annual net income divided by reported headcount, normalized to US dollars; years with a net loss dip below zero.
| Fiscal year | Earnings per employee (USD) |
|---|---|
| 1996 | $19.7K |
| 1997 | $27.8K |
| 1998 | $28.4K |
| 1999 | $33.8K |
| 2000 | $36.7K |
| 2001 | $12.2K |
| 2002 | $30K |
| 2003 | $31.2K |
| 2004 | $37.7K |
| 2005 | $33.6K |
| 2006 | $35.3K |
| 2007 | $24.6K |
| 2008 | $40.9K |
| 2009 | $50.5K |
| 2010 | $59.4K |
| 2011 | $65.8K |
| 2012 | $68.9K |
| 2013 | $78.8K |
| 2014 | $84.2K |
| 2015 | $81.3K |
| 2016 | $67.1K |
| 2017 | $56.3K |
| 2018 | $53.1K |
| 2019 | $55.9K |
| 2020 | $80K |
| 2021 | $59.5K |
| 2022 | $95.5K |
| 2023 | $88.5K |
| 2024 | $102K |
| 2025 | $132K |
Employee count history for ResMed (RMD)
Annual figures come from annual reports (10-K, or 20-F/40-F for foreign filers); interim rows reflect headcount disclosed in periodic filings. Year-over-year change compares each filing with the prior year's equivalent. Revenue and earnings per employee are annual figures normalized to US dollars.
- 202510,600+6.2%
- 20249,980-1.6%
- 202310,140+24.3%
- 20228,160+2.4%
- 20217,970+2.6%
- 20207,770+7.3%
- 20197,240+21.9%
- 20185,940-2.3%
- 20176,080+15.8%
- 20165,250+21.0%
- 20154,340+5.9%
- 20144,100+5.1%
- 20133,900+5.4%
- 20123,700+7.2%
- 20113,450+7.8%
- 20103,200+10.3%
- 20092,900+7.4%
- 20082,7000.0%
- 20072,700+8.0%
- 20062,500+29.7%
- 20051,927+26.8%
- 20041,520+3.8%
- 20031,464+17.1%
- 20021,250+31.2%
- 2001953+57.5%
- 2000605+26.8%
- 1999477+27.9%
- 1998373+38.1%
- 1997270+17.9%
- 1996229—
About ResMed's employee count
ResMed (RMD) employed 10,600 people in fiscal year 2025, based on its most recent annual report. That headcount grew by +620 (+6.2%) from 9,980 a year earlier.
Across the 1996–2025 period, the company's reported workforce went from 229 to 10,600 employees — a compound annual growth rate (CAGR) of +14.1% per year.
ResMed generated about $486K of revenue and $132K of net income per employee in its latest annual period. Revenue and earnings per employee gauge how efficiently a company turns headcount into output, and are most telling when tracked over time or compared with peers in the same industry.
Frequently asked questions
Test yourself on RMD
Employees — 10 rounds, every one of them RMD against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.82% TTM
- Dividend Profile1.14% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.